CD79A and Miyoshi myopathy: Upon progression, the hematologic status of most individuals with IgG, IgA, or free light chain (FLC) MGRS progress into multiple myeloma (MM) or systemic light chain amyloidosis, while most individuals with IgM MGRS tend to develop Waldenström macroglobulinemia (WM) or other lymphoproliferative disorders.